Jochen Reiser

This inventor holds 9 USPTO granted patents and 16 published patent applications and 5 EPO patents. Top assignees: The General Hospital Corporation, Rush University Medical Center, University of Miami. Active years: 2010-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jochen Reiser. Retrieved from https://idiyas.com/inventor/jochen-reiser

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 16)

% Patents Active = 77.8

EPO Patents = 5 (Patent Applications = 13)

Average Co-Inventor Count = 1.6

ph-index = 1

Forward Citations = 3(Granted Patents)

Location History:

North Reading, MA (US) (2010)
Miami, FL (US) (2014 - 2016)
Hinsdale, IL (US) (2018 - 2020)

Company Filing History:

4 out of 3,076

The General Hospital Corporation

patents

3 out of 114

Rush University Medical Center

where one patent can have more than one assignee

Years Active: 2010-2025

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12492250 - suPAR and prediction and treatment of acute kidney injury (2025-12-09),

2. 12326457 - ICOSL for use as a renal therapeutic (2025-06-10),

3. 10526579 - Podocyte cultures and uses thereof (2020-01-07),

4. 9867923 - Reducing soluble urokinase receptor in the circulation (2018-01-16),

5. 9345739 - Methods and compositions for the treatment of proteinuric diseases (2016-05-24),

6. 9205135 - Podocyte pH modulation and uses thereof (2015-12-08),

7. 9144594 - Cathepsin L mediated diseases and associated methods and products (2015-09-29),

8. 8668927 - Dynamin mediated diseases and associated methods and products (2014-03-11),

9. 7670817 - Dynamin mediated diseases and associated methods and products (2010-03-02),

Title: Jochen Reiser: Innovator in Kidney Injury Treatment

Introduction

Jochen Reiser is a prominent inventor based in Miami, FL (US), known for his significant contributions to the field of renal therapeutics. With a total of 9 patents to his name, Reiser has focused on innovative methods for predicting and treating acute kidney injury.

Latest Patents

Among his latest patents, Reiser has developed methods and compositions for treating acute kidney injury. These methods involve measuring the level of soluble urokinase plasminogen activator receptor (suPAR) in a biological sample from a subject. By comparing the suPAR level in the sample to a control level, a therapeutically effective amount of an agent that antagonizes suPAR can be administered to subjects with elevated levels. Additionally, he has patented methods for treating aberrant activation of αvβ integrin using inducible co-stimulator ligand (ICOSL) polypeptide, which is crucial for subjects in need of renal therapeutic interventions.

Career Highlights

Reiser has worked with notable institutions, including The General Hospital Corporation and the University of Miami. His work has significantly advanced the understanding and treatment of kidney injuries, showcasing his dedication to improving patient outcomes.

Collaborations

Throughout his career, Reiser has collaborated with esteemed colleagues such as Sanja Sever and Eunsil Hahm. These partnerships have further enriched his research and innovation in the field.

Conclusion

Jochen Reiser's contributions to kidney injury treatment through his innovative patents and collaborations highlight his role as a leading inventor in the medical field. His work continues to pave the way for advancements in renal therapeutics.

Profile summary based on public USPTO records.